Litigation Details for AstraZeneca AB v. Alembic Pharmaceuticals Limited (D. Del. 2020)
✉ Email this page to a colleague
AstraZeneca AB v. Alembic Pharmaceuticals Limited (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-02-11 |
Court | District Court, D. Delaware | Date Terminated | 2022-04-25 |
Cause | 35:1 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 10,183,020 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca AB v. Alembic Pharmaceuticals Limited
Details for AstraZeneca AB v. Alembic Pharmaceuticals Limited (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-04-25 | 228 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,183,020. (Attachments: # 1…2020 25 April 2022 1:20-cv-00202 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2020-02-11 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,183,020. (lak) (Entered: 02…2020 25 April 2022 1:20-cv-00202 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |